Skip to content
HowShorted

Tyra Biosciences, Inc. short interest in 2024

In 2024, Tyra Biosciences, Inc.'s disclosed short interest ran from 4.37% of shares outstanding on 12 Jan 2024 to 5.01% on 31 Dec 2024, a change of +0.64 percentage points. The year's high was 6.55% on 30 Apr 2024 and its low 3.33% on 31 Oct 2024, averaging 4.55% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.64 days on 31 Jan 2024. Full history: Tyra Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tyra Biosciences, Inc. in 2024

2024 in figures

Start of year
4.37% (12 Jan 2024)
End of year
5.01% (31 Dec 2024)
Change
+0.64 pp
High
6.55% (30 Apr 2024)
Low
3.33% (31 Oct 2024)
Average
4.55%
Highest days to cover
45.64 (31 Jan 2024)
SEC filings marked
8

Every report in 2024

Tyra Biosciences, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20244.37%17.04
31 Jan 20244.73%45.64
15 Feb 20245.28%9.82
29 Feb 20245.63%33.40
15 Mar 20244.95%18.75
28 Mar 20245.38%15.6910-K filed, results (8-K)
15 Apr 20246.23%25.98
30 Apr 20246.55%28.66
15 May 20243.90%15.3910-Q filed, results (8-K)
31 May 20243.73%17.13
14 Jun 20243.61%10.03
28 Jun 20243.74%6.48
15 Jul 20244.21%20.00
31 Jul 20244.23%18.41
15 Aug 20244.18%11.1910-Q filed, results (8-K)
30 Aug 20244.29%15.18
13 Sep 20244.54%25.38
30 Sep 20244.51%11.07
15 Oct 20244.16%13.04
31 Oct 20243.33%2.28
15 Nov 20243.70%5.1910-Q filed, results (8-K)
29 Nov 20243.97%10.25
13 Dec 20245.01%11.60
31 Dec 20245.01%12.78

See also: Tyra Biosciences, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.